Skip to main content
. 2017 Sep 25;24(1):1429–1440. doi: 10.1080/10717544.2017.1377315

Table 2.

Effect of doxycycline hydrochloride and DCNPopt on various behavioral and biochemical parameters.

  Vehicle Keta (50 mg/kg) Keta + Olz (5 mg/kg) Keta + Placebo (50 mg/kg) Keta + Doxy (25 mg/kg) Keta + Doxy (50 mg/kg) Keta + DCNPopt (25 mg/kg)
Locomotor counts 283.33 ± 9.61 502.66 ± 7.46* 359.33 ± 10.44a 490.50 ± 11.55 444.83 ± 19.61 394.16 ± 8.42a 304.33 ± 23.4a,x,q
Stereotyped behaviors 2.50 ± 0.34 27.66 ± 1.14* 7.83 ± 0.6a 26.50 ± 0.84 21.16 ± 1.74b 18.66 ± 1.47a 11.16 ± 1.49a,x,q
Immobility duration (s) 72.5 ± 1.61 149.83 ± 1.88* 81.83 ± 1.49a 146.33 ± 1.99 125.16 ± 2.93a 114.50 ± 3.08a 81.16 ± 5.16a,x,p
SDL (s) 237.66 ± 14.55 76.83 ± 3.98* 186 ± 2.22a 74.16 ± 4.01 80.16 ± 4.52 80.50 ± 4.52 90.83 ± 3.17#
TNF-α (ng/ml) 125.16 ± 3.65 499.66 ± 9.62* 128.00 ± 2.58a 495.33 ± 12.02 378.66 ± 5.56a 330.33 ± 15.51a 147.33 ± 4.77a,x,p
GSH (nmol/mg protein) 0.0051 ± 0.00020 0.0015 ± 0.00011* 0.0051 ± 0.00016a 0.0016 ± 9.38E-50 0.0029 ± 2.72E-04a 0.0038 ± 0.00011a 0.0053 ± 1.69E-03a,x,p
MDA (nmol/mg protein) 0.252 ± 0.014 0.563 ± 0.019* 0.228 ± 0.011a 0.558 ± 0.020 0.424 ± 0.010a 0.396 ± 0.007a 0.208 ± 0.08a,x,p
AchE (nmol/min/g protein) 38.82 ± 1.24 65.24 ± 2.05* 36.68 ± 1.92a 64.79 ± 3.90 64.74 ± 1.68 64.25 ± 3.11 62.67 ± 1.41#
Dopamine (pg/mg brain) 427.38 ± 27.11 981.73 ± 30.68* 429.62 ± 29.03a 978.40 ± 25.40 688.33 ± 21.12a 642.93 ± 27.21a 435.16 ± 21.55a,x,p
GABA (μg/g brain) 192.58 ± 6.75 107.80 ± 6.06* 208.88 ± 8.80a 106.42 ± 6.11 147.50 ± 3.22a 155.99 ± 3.56a 211.30 ± 5.62a,x,p

Values are expressed as mean ± SEM (n = 6).

*

p < .001 vs vehicle group.

a

p < .001 vs ketamine group.

x

p < .001 vs Keta + Doxy (25 mg/kg).

p

p < .001 vs Keta + Doxy (50 mg/kg).

q

p < .01 vs Keta + Doxy (50 mg/kg).

#

p < .001 vs olanzapine.

Keta: Ketamine; Olz: Olanzapine; Doxy: Doxycycline hydrochloride; DCNPopt: Optimized Doxycycline hydrochloride Chitosan Nanoparticles.